Insulin Pump Therapy for the Patient With Diabetes
Thanks to technological improvements in continuous subcutaneous insulin infusion (CSII) pumps, encouraging data on CSII pump use in patients with type 2 diabetes, and improved insurance coverage, primary care practitioners will be increasingly likely to manage patients using CSII pumps. An understanding of the basics of insulin pump therapy will enhance clinicians’ collaborative efforts with the patient and the diabetes care team.
28. Green JB, Lane WS, Bergenstal RM, et al. Insulin Pump Settings Associated with Degree of Glycemic Improvement in Adults with Type 1 Diabetes Using Sensor-Augmented Pump Therapy. Presented at: Diabetes Technology Meeting; November 11-13, 2010; Bethesda, MD. Abstract A51.
29. Buse JB, Kidva YC, Guthrie RA, et al. Assessment of glycemic variability and CD40 ligand in the STAR 3 Study. Presented at: American Diabetes Association Scientific Sessions; June 2, 2011; San Diego, CA. Abstract 0923-P.
30. Hirsch IB. Algorithms for care in adults using continuous glucose monitoring. J Diabetes Sci Technol. 2007;1(1):126-129.
31. Wolpert HA. Continuous glucose monitoring: coming of age (editorial). N Engl J Med. 2010;363(4):383-384.
32. Wiegand S, Raile K, Reinehr T, et al; DPV-Wiss Study Group. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, body mass index and mode of therapy. Eur J Endocrinol. 2008;158(4):543-549.
33. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes. 2006;7 suppl 4:32-38.
34. Unger J. A primary care approach to continuous subcutaneous insulin infusion. Clin Diabetes. 1999;17(3). https://journal.diabetes.org/clinicaldiabetes/V17N31999/Pg113.htm. Accessed October 21, 2011.
